REGENERATIVE MEDICINE CROSSING BORDERS
TERMIS 6th world conference in 2021
Biologically inspired technology driven regenerative medicine
The next TERMIS world conference will be held in 2021 from May 31st until June 4th in Maastricht. The organizing committee looks forward to the participation of the whole regenerative medicine community across the Netherlands, Belgium & Germany.
3rd International NanoBio Surfaces and Interfaces in health care and science
The 3rd International NanoBio Surfaces and Interfaces in health care and science in conjunction with the CMi annual review meeting at EPFL, 8 May 2018 at the Rolex Learning Center (RLC) at EPFL.
kick-off symposium van het MDR Zwaartekracht-programma
Op 2 februari vindt in Eindhoven (ICMS) het kick-off symposium van het MDR Zwaartekracht-programma plaats.
Innovation for Health
Innovation for Health is the Netherlands´ premier conference for key players in Health and Life Sciences. It brings together key players and stakeholders who play decisive parts in the development, funding and implementation of innovations for prevention and healthcare. Innovation for Health is a high-end conference, it offers a dynamic exhibition and a central meeting place. It provides a great opportunity to meet leading innovators, to catch up on the latest trends, to present cutting-edge innovations and to engage leaders and decision makers in healthcare innovation.
With more than 800 delegates, 8 main tracks, over 50 influential speakers, 10 innovation pitches and many of one-on-one meetings, Innovation for Health is an inspirational event for professionals in health and care, from bench to boardroom, from start-up to multinational.
RegMed XB Director Prof. Marianne van der Steen will be presenting RegMed XB during this event!
ICMS Outreach Symposium
This is a fantastic conference and for RegMed XB especially the second day is relevant as the recently granted Gravitation program “Materials-Driven Regeneration”, spearheaded by Carlijn Bouten, in collaboration with partners from Regenerative Medicine Utrecht (RMU) and the Institute for Technology-Inspired Regenerative Medicine (MERLN) in Maastricht, will be presented by the Consortium members. The central goal of this program is to investigate, design and use intelligent biomaterials that drive and reinforce the body’s own regenerative power to contribute to the curing of a number of chronic diseases. It excites us that renowned speakers will headline their cutting-edge strategies in the area of biomaterials for the benefit of regenerative medicine during this Symposium.
NWA-routes conferentie
Eén jaar na de presentatie van het Portfolio voor onderzoek en innovatie is er veel gebeurd binnen de 25 routes van de Nationale Wetenschapsagenda. Tijd om te reflecteren op het proces en de ontwikkeling van nieuwe samenwerkingsverbanden, resultaten te delen en nieuwe mogelijkheden voor co-creatie en kennisbenutting te verkennen. Dat doen we graag samen met de vertegenwoordigers van de routes en hun netwerken tijdens de NWA-routes conferentie op 31 oktober in Nieuwegein.
https://wetenschapsagenda.nl/activiteit/nwa-routes-conferentie/
TEDxMaastricht 2017
Pre-registration for TEDxMaastricht 2017 is now closed!
The process of Inception
TEDxMaastricht thinks that planting a seed is just the beginning.
The quality and impact of an idea is largely formed by the right soil, breeding ground or pressure cooker. If the environment is nourishing and the hand of time is on your side, your idea will be able to evolve into a mature concept.
Therefore TEDxMaastricht challenges our speakers to not only share their success, but also to inspire our audiences to take action and initiative by showing them the context in which their idea was founded. This brings the hero TEDx speaker closer to the individual trying to take action.
Visionary Seminar
A regenerative medicine hotspot is emerging in The Netherlands and Flanders. What visions drive research and valorisation efforts? Two expert moderators will explore the visionary potential of eight eminent speakers and panelists from The Netherlands and Flanders, covering the entire value chain from the research community and clinicians to start-ups and big companies.
